Related Experiment Video
Updated: Aug 6, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Bile Acid Derivatives Effectively Prevented High-Fat Diet-Induced Colonic Barrier Dysfunction
Yafang Ma1, Kai Shan1, Zixin Huang1
1Key Laboratory of Meat Processing and Quality Control, MOE; Key Laboratory of Meat Processing, MOA; Jiangsu Synergetic Innovation Center of Meat Processing and Quality Control, Nanjing Agricultural University, Nanjing, 210095, P. R. China.
High-fat diets disrupt colonic barrier function by altering bile acids (BAs). Secondary BAs, particularly isomerized forms like isoDCA and isoLCA, protect the gut barrier and may prevent diet-induced damage.
Area of Science:
- Gastroenterology
- Microbiology
- Metabolism
Background:
- Bile acids (BAs) are key regulators of physiological and pathological processes.
- The impact of high-fat diets (HFDs) on colonic BAs and barrier function requires further investigation.
Purpose of the Study:
- To elucidate the changes in colonic bile acids induced by HFDs.
- To investigate the effects of these altered bile acids on colonic barrier function.
Main Methods:
- Mice were fed HFDs for 12 weeks, and intestinal permeability markers (DAO, ET, d-LA) were measured.
- Colonic expression of tight junction proteins (TJs) and Muc2 was analyzed using qPCR and Western blot.
- Colonic BA profiles were determined using UPLC-MS/MS; effects of BAs on Caco-2 cells and HFD-fed mice were assessed.
Main Results:
- HFDs increased intestinal permeability and decreased TJ and Muc2 expression in mice.
- HFDs altered colonic BA profiles, increasing primary BAs and decreasing secondary BAs.
- Secondary BAs, especially isomerized forms (isoDCA, isoLCA), upregulated TJs and counteracted permeability increases in vitro and in vivo.
Conclusions:
- Secondary bile acids, particularly isomerized derivatives, are crucial protectors of colonic barrier function.
- These findings suggest a therapeutic potential for secondary BAs in managing HFD-induced gut barrier dysfunction.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

